Abstract 4034: A potent and highly selective irreversible HER2 inhibitor for treating HER2-driven cancers

Authors: Chunmei Zhao, Lana Kulyk, Iriny Botrous, Kelly Chen, Chang Zhao, Afsheen Banisadr, Mary L. Anderson, Fred Manby, Tom Miller, Chao Zhang, Laurent Gomez, Zhongdong Huang

Published: 2023-04-04

DOI: 10.1158/1538-7445.am2023-4034

Source: Full article